Results 211 to 220 of about 461,500 (311)

Characterisation of the Mesial Root and Middle Mesial Canal Morphology in Mandibular First Molars: An Ex Vivo Micro‐CT Study

open access: yesAustralian Endodontic Journal, EarlyView.
ABSTRACT This ex vivo study characterised the mesial root morphology of mandibular first molars with a middle mesial canal (MMC) using micro‐CT. Among 469 scanned molars, 42 (8.96%) presented an MMC. Morphological parameters analysed included canal configuration, chamber orifice features, dentine thickness, isthmus type, and aspect ratio.
Nuno Rodrigues dos Santos   +3 more
wiley   +1 more source

Suplementação com ferro na gravidez: haverá benefícios clínicos?

open access: yesRevista Portuguesa de Medicina Geral e Familiar, 2016
Ana Carlota Dias   +3 more
doaj   +1 more source

Brief report: Ketamine‐assisted “bridge therapy” for opioid tapering in complex cases

open access: yesThe American Journal on Addictions, EarlyView.
Abstract Background Opioid use disorder (OUD) presents major challenges, especially when combined with chronic pain and psychiatric comorbidities. A 25‐year‐old woman with OUD, chronic pain, and major depressive disorder underwent an 8‐week protocol of intravenous ketamine infusions (0.5 mg/kg weekly) as an adjunct to opioid tapering. Results Methadone
Mariana C. de Oliveira   +11 more
wiley   +1 more source

Qual o alvo ideal para o tratamento da hipertensão?

open access: yesRevista Portuguesa de Medicina Geral e Familiar, 2016
Ana Rita Domingues   +3 more
doaj   +1 more source

[Usefulness and reliability of point of care ultrasound in Family Medicine: Focused cardiac and lung ultrasound]. [PDF]

open access: yesAten Primaria, 2019
Diaz Sánchez S   +5 more
europepmc   +1 more source

FACTORES DE RIESGO PARA EL DESTETE TEMPRANO EN LA UNIDAD DE MEDICINA FAMILIAR 64 [PDF]

open access: yes, 2014
Gaytán Núñez, Fátima Korina   +1 more
core  

Personalized Cancer Vaccines in the Clinical Trial Pipeline

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
This study analyzes the current landscape of personalized cancer vaccine clinical trials, highlighting trends in vaccine platforms, trial phases, and geographic distribution. Peptide and dendritic cell vaccines dominate early‐stage research, with promising immune responses observed in melanoma, glioblastoma, and urothelial cancer trials.
Liudmila Iamukova, Elena Alferova
wiley   +1 more source

Home - About - Disclaimer - Privacy